Kelsey L Richardson1, R Scott Watson2,3, Sangeeta Hingorani4,5. 1. Division of Pediatric Nephrology, Oregon Health & Science University, 707 SW Gaines Street, Portland, OR, 97239, USA. richarke@ohsu.edu. 2. Division of Pediatric Critical Care Medicine, Department of Pediatrics, University of Washington, Seattle, USA. 3. Center for Child Health, Behavior and Development, Seattle Children's Research Institute, Seattle, USA. 4. Division of Pediatric Nephrology, Department of Pediatrics, University of Washington, Seattle, USA. 5. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, USA.
Abstract
OBJECTIVES: Acute kidney injury (AKI) is common in hospitalized children. The impact of AKI following hospitalization is not fully understood, particularly the impact on health related quality of life (HRQOL). The goal of this study was to determine the relationship between hospitalization-associated AKI and HRQOL in a pediatric population. STUDY DESIGN: We conducted a retrospective cohort study of children with hospitalization-associated AKI. Eligible children were 1-19 years old with AKI defined by kidney disease improving global outcomes (KDIGO) criteria and had at least one completed pediatric quality of life (PedsQL) 4.0 Generic Core Scale survey (N = 139). Participants completed up to three surveys to reflect baseline, admission and follow-up status. We categorized children as having mild AKI (KDIGO stage 1, N = 73) or severe AKI (KDIGO stage 2 or 3, N = 66). Mean PedsQL scores were compared by AKI group. Those with both baseline and follow-up surveys were analyzed to determine the proportion who returned to their baseline level of function within 8 weeks of discharge. RESULTS: Children with mild and severe AKI had similar baseline and admission PedsQL scores. Although children with severe AKI had lower follow-up scores, the results were not statistically significant (78.9 vs. 85.8, p = 0.11). Of those with severe AKI, 48% returned to their baseline level of physical functioning by follow-up, compared to 73% with mild AKI (p = 0.05). CONCLUSIONS: This is the first study of HRQOL following hospitalization-associated AKI. We found that children with severe AKI had depressed physical functioning after discharge when compared to children with mild AKI.
OBJECTIVES:Acute kidney injury (AKI) is common in hospitalized children. The impact of AKI following hospitalization is not fully understood, particularly the impact on health related quality of life (HRQOL). The goal of this study was to determine the relationship between hospitalization-associated AKI and HRQOL in a pediatric population. STUDY DESIGN: We conducted a retrospective cohort study of children with hospitalization-associated AKI. Eligible children were 1-19 years old with AKI defined by kidney disease improving global outcomes (KDIGO) criteria and had at least one completed pediatric quality of life (PedsQL) 4.0 Generic Core Scale survey (N = 139). Participants completed up to three surveys to reflect baseline, admission and follow-up status. We categorized children as having mild AKI (KDIGO stage 1, N = 73) or severe AKI (KDIGO stage 2 or 3, N = 66). Mean PedsQL scores were compared by AKI group. Those with both baseline and follow-up surveys were analyzed to determine the proportion who returned to their baseline level of function within 8 weeks of discharge. RESULTS:Children with mild and severe AKI had similar baseline and admission PedsQL scores. Although children with severe AKI had lower follow-up scores, the results were not statistically significant (78.9 vs. 85.8, p = 0.11). Of those with severe AKI, 48% returned to their baseline level of physical functioning by follow-up, compared to 73% with mild AKI (p = 0.05). CONCLUSIONS: This is the first study of HRQOL following hospitalization-associated AKI. We found that children with severe AKI had depressed physical functioning after discharge when compared to children with mild AKI.
Entities:
Keywords:
Acute kidney injury (AKI); Outcomes; Pediatric; Quality of life (QOL)
Authors: Annika Ahlström; Minna Tallgren; Seija Peltonen; Pirjo Räsänen; Ville Pettilä Journal: Intensive Care Med Date: 2005-07-28 Impact factor: 17.440
Authors: Cherry Mammen; Abdullah Al Abbas; Peter Skippen; Helen Nadel; Daniel Levine; J P Collet; Douglas G Matsell Journal: Am J Kidney Dis Date: 2011-12-28 Impact factor: 8.860
Authors: Michael Zappitelli; Chirag R Parikh; Ayse Akcan-Arikan; Kimberley K Washburn; Brady S Moffett; Stuart L Goldstein Journal: Clin J Am Soc Nephrol Date: 2008-04-16 Impact factor: 8.237
Authors: Sara Nisula; Suvi T Vaara; Kirsi-Maija Kaukonen; Matti Reinikainen; Simo-Pekka Koivisto; Outi Inkinen; Meri Poukkanen; Pekka Tiainen; Ville Pettilä; Anna-Maija Korhonen Journal: Crit Care Date: 2013-10-22 Impact factor: 9.097
Authors: Robert Faulhaber-Walter; Sebastian Scholz; Herrmann Haller; Jan T Kielstein; Carsten Hafer Journal: Int J Nephrol Renovasc Dis Date: 2016-05-23
Authors: Scott L Weiss; Fran Balamuth; Cary W Thurm; Kevin J Downes; Julie C Fitzgerald; Benjamin L Laskin Journal: Clin J Am Soc Nephrol Date: 2019-04-18 Impact factor: 8.237
Authors: Michelle C Starr; Russell Banks; Ron W Reeder; Julie C Fitzgerald; Murray M Pollack; Kathleen L Meert; Patrick S McQuillen; Peter M Mourani; Ranjit S Chima; Samuel Sorenson; James W Varni; Sangeeta Hingorani; Jerry J Zimmerman Journal: Pediatr Crit Care Med Date: 2020-09 Impact factor: 3.971